Business Description
Klotho Neurosciences Inc
NAICS : 541714
SIC : 2833
ISIN : US03465T1088
Description
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.16 | |||||
| 9-Day RSI | 41.45 | |||||
| 14-Day RSI | 39.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.16 | |||||
| Quick Ratio | 0.16 | |||||
| Cash Ratio | 0.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -8.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -4536.67 | |||||
| ROA % | -150.94 | |||||
| ROIC % | -136.72 | |||||
| ROCE % | -283.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.76 | |||||
| EV-to-EBIT | -1.76 | |||||
| EV-to-EBITDA | -1.76 | |||||
| EV-to-FCF | -3.33 | |||||
| Earnings Yield (Greenblatt) % | -56.82 | |||||
| FCF Yield % | -30.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KLTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Klotho Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.211 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 39.68 | ||
| 14-Day ATR ($) | 0.06685 | ||
| 20-Day SMA ($) | 0.366345 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.26 - 5.11 | ||
| Shares Outstanding (Mil) | 21.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Klotho Neurosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Klotho Neurosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Klotho Neurosciences Inc Frequently Asked Questions
What is Klotho Neurosciences Inc(KLTO)'s stock price today?
The current price of KLTO is $0.34. The 52 week high of KLTO is $5.11 and 52 week low is $0.26.
When is next earnings date of Klotho Neurosciences Inc(KLTO)?
The next earnings date of Klotho Neurosciences Inc(KLTO) is .
Does Klotho Neurosciences Inc(KLTO) pay dividends? If so, how much?
Klotho Neurosciences Inc(KLTO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers